Feasibility and Safety of Neoadjuvant Alectinib in a Patient With ALK-Positive Locally Advanced NSCLC

被引：28
作者：
Zhang, Chao [1 ,2 ]
Yan, Li-Xu [2 ,3 ]
Jiang, Ben-Yuan [1 ,2 ]
Wu, Yi-Long [1 ,2 ]
Zhong, Wen-Zhao [1 ,2 ]
机构：
[1] Guangdong Prov Peoples Hosp, Guangdong Prov Key Lab Translat Med Lung Canc, Guangdong Lung Canc Inst, Guangzhou, Peoples R China
[2] Guangdong Acad Med Sci, Guangzhou 510080, Guangdong, Peoples R China
[3] Guangdong Prov Peoples Hosp, Dept Pathol, Guangzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2020年 / 15卷 / 06期
关键词：
D O I：
10.1016/j.jtho.2019.12.133
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E95 / E99
页数：5
相关论文
共 5 条
[1]   Dynamic changes in PD-L1 expression and CD8+ T cell infiltration in non small cell lung cancer following chemoradiation therapy [J].
Choe, Eun-Ah ;
Cha, Yoon Jin ;
Kim, Jae-Hwan ;
Pyo, Kyoung Ho ;
Hong, Min Hee ;
Park, Seong Yong ;
Shim, Hyo Sup ;
Jung, Inkyung ;
Lee, Chang Young ;
Cho, Byoung Chul ;
Kim, Hye Ryun .
LUNG CANCER, 2019, 136 :30-36
[2]   Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK plus ) non-small-cell lung cancer: CNS efficacy results from the ALEX study [J].
Gadgeel, S. ;
Peters, S. ;
Mok, T. ;
Shaw, A. T. ;
Kim, D. W. ;
Ou, S. I. ;
Perol, M. ;
Wrona, A. ;
Novello, S. ;
Rosell, R. ;
Zeaiter, A. ;
Liu, T. ;
Nuesch, E. ;
Balas, B. ;
Camidge, D. R. .
ANNALS OF ONCOLOGY, 2018, 29 (11) :2214-2222
[3]   Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer [J].
Peters, Solange ;
Camidge, D. Ross ;
Shaw, Alice T. ;
Gadgeel, Shirish ;
Ahn, Jin S. ;
Kim, Dong-Wan ;
Ou, Sai-Hong I. ;
Perol, Maurice ;
Dziadziuszko, Rafal ;
Rosell, Rafael ;
Zeaiter, Ali ;
Mitry, Emmanuel ;
Golding, Sophie ;
Balas, Bogdana ;
Noe, Johannes ;
Morcos, Peter N. ;
Mok, Tony .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (09) :829-838
[4]   Neoadjuvant Crizotinib in Resectable Locally Advanced Non-Small Cell Lung Cancer with ALK Rearrangement [J].
Zhang, Chao ;
Li, Shao-lei ;
Nie, Qiang ;
Dong, Song ;
Shao, Yang ;
Yang, Xue-ning ;
Wu, Yi-long ;
Yang, Yue ;
Zhong, Wen-zhao .
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (04) :726-731
[5]   Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 EGFR-Mutant Non-Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study [J].
Zhong, Wen-Zhao ;
Chen, Ke-Neng ;
Chen, Chun ;
Gu, Chun-Dong ;
Wang, Jun ;
Yang, Xue-Ning ;
Mao, Wei-Min ;
Wang, Qun ;
Qiao, Gui-Bin ;
Cheng, Ying ;
Xu, Lin ;
Wang, Chang-Li ;
Chen, Ming-Wei ;
Kang, Xiaozheng ;
Yan, Wanpu ;
Yan, Hong-Hong ;
Liao, Ri-Qiang ;
Yang, Jin-Ji ;
Zhang, Xu-Chao ;
Zhou, Qing ;
Wu, Yi-Long .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (25) :2235-+
1